Scarica l'app Stockscreener
1.32
0.00%
0.00
Dopo l'orario di chiusura:
1.32
Bioatla Inc Borsa (BCAB) Ultime notizie
BioAtla (BCAB) Financial Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Investor Response: Shares Finish 3.46% Higher in the Latest SessionWeak Earnings Momentum - vinanet.vn
BioAtla Inc. (BCAB) Tumbles 10.4% to $3.09 as Bearish Momentum Tests Key $2.94 SupportTurnaround Stocks - Vinanet
Bioatla Stock Price Forecast. Should You Buy BCAB? - StockInvest.us
BioAtla, Inc. Q2 2026: Revenue $6.5M, EPS $0.27— 10-Q Summary - TradingView
BioAtla (BCAB) turns Q2 2026 profit as cash falls and going concern risk emerges - Stock Titan
BioAtla, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Bioatla Inc (BCAB) Stock News Today - TradingKey
Bioatla Inc (BCAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioAtla (BCAB) Climbs 3.9% to $3.46 as Buyers Step In Near SupportButterfly Setup - Vinanet
BCAB Q2'26 Earnings: EPS estimate is (8.50) USD - TradingView
BioAtla Inc. (BCAB) Slips 2.37% to $3.3 as Shares Hover Near Key Support at $3.13Quality ETF - vinanet.vn
BCAB Q4 2025 Earnings: EPS Beat Signals Tightened Cash Management Amid No Revenue MilestonesOne-Time Gain Impact - Vinanet
BCAB|Bioatla Inc|Price:3.460|Chg%:+0.130 - TradingKey
BioAtla (BCAB) Slips 3.76% as Shares Approach Critical Support ZoneGap Fill Strategy - vinanet.vn
Bioatla Inc (BCAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bioatla Inc (BCAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioatla Inc (BCAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bioatla Inc (BCAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioatla Inc (BCAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioAtla, Inc. Revenue Breakdown – NASDAQ:BCAB - TradingView
Bioatla Inc (BCAB) Balance Sheet - TradingKey
Bioatla Inc (BCAB) Income Statement - TradingKey
TradingKey - TradingKey
BCAB|Bioatla Inc|Price:3.280|Chg%:-0.010 - TradingKey
BCAB|Bioatla Inc|Price:3.360|Chg%:-0.010 - TradingKey
Bioatla Inc (BCAB) Institutional Confidence - TradingKey
Bioatla Inc (BCAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioAtla Inc. (BCAB) Moves Higher: Biotech Stock Tests Key Resistance at $3.63Change of Character - dars.gov.et
BioAtla Company Profile & Introduction - Moomoo
BioAtla Inc. (BCAB) Holds Near Key Support as Slight Decline Tests Investor ConvictionIron Condor Alert - vinanet.vn
BioAtla Inc. (BCAB) Edges Lower Amid Consolidation, Testing Key Support LevelsNAAIM Exposure - dars.gov.et
BioAtla Shareholders Back Directors, Auditor and Pay Plan - The Globe and Mail
BioAtla, Inc. 8-K SEC Filing: Company Profile, Key Data, and Stock Information for July 2026 - Minichart
BCAB Q4 2025 Earnings: Substantial EPS Beat Signals Progress in Development PipelineBook Value Growth - vinanet.vn
BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Provides OptimismEarnings Miss Streak - DonanımHaber
BioAtla Inc. (BCAB) Q4 2025 Earnings: Narrower Net Loss Surpasses Expectations as Clinical Pipeline ProgressesBasic EPS Analysis - dars.gov.et
BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Surprises Markets as Stock DeclinesTax Rate Impact - dars.gov.et
BioAtla Inc. (BCAB) Surges Nearly 6% as Shares Test Key Resistance LevelStraddle Setup - dars.gov.et
BCAB Q4 2025 Earnings: Narrowing Losses Beat Street Estimates as Stock Rises 4%Annual Financial Report - po-news-eg.net
Price to sales forward of BioAtla, Inc. – NASDAQ:BCAB - TradingView
Enterprise value to revenue forward of BioAtla, Inc. – NASDAQ:BCAB - TradingView
BioAtla, Inc. Actuals & Estimates (NASDAQ:BCAB) - TradingView
BCAB Forecast — Price Target — Prediction for 2027 - TradingView
BioAtla: BioAtla, Inc.Reverse Split Option Symbol: BCAB New Symbol: BCAB1 - Moomoo
BioAtla Inc. (BCAB) Jumps Over 7% as Biotech Momentum BuildsValue Area Low - dars.gov.et
Bioatla Inc (BCAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Surprises; Shares Edge HigherEarnings Surprise Report - dars.gov.et
BioAtla (BCAB) Q4 2025 Earnings: Narrowed Loss Beats Expectations as Stock AdvancesEarnings Expansion Phase - dars.gov.et
BioAtla Inc. (BCAB) Q4 2025 Earnings: Narrowed Loss and Positive Surprise Boost Investor SentimentMargin Guidance - dars.gov.et
BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionEPS Consistency Score - newsline.com
BCAB Q4 2025 Earnings: Narrower Loss Surprises, Shares RiseLow Estimate Range - newsline.com
BioAtla Inc. (BCAB) Slips 2.5% as Shares Test Key Support ZoneBearish Pattern Stocks - newsline.com
BioAtla (BCAB) Slips 4.58% as Stock Nears Critical Support LevelTotal Put Call - newsline.com
BioAtla Inc. (BCAB) Drops 4.58% as Stock Hovers Near Key Support LevelSynthetic Long - dars.gov.et
BCAB Q4 2025 Earnings: Narrower-Than-Expected Loss Offers Partial Offset Amid Stock DeclineAnalyst Consensus Shift - newsline.com
BCAB Q4 2025 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Amid Pipeline ProgressROA Comparison - newsline.com
BioAtla Inc. (BCAB) Q4 2025 Earnings: EPS Beat Driven by Lower Operating Loss, Stock DeclinesConsensus Beat Rate - dars.gov.et
BioAtla (NASDAQ: BCAB) CFO logs non-sale share withholdings for RSU taxes - Stock Titan
BioAtla (BCAB) CMO has 494 shares withheld to cover RSU taxes - Stock Titan
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):